We are live on
!
Find out more
RP
Riverbridge Partners Portfolio holdings
AUM
$3.58B
1-Year Est. Return
4.02%
This Fund
S&P 500
This Quarter
Est. Return
+22.37%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$9.05B
AUM Growth
+$1.89B
(+26%)
Cap. Flow
+$444M
Cap. Flow
% of AUM
4.9%
Top 10 Holdings %
Top 10 Hldgs %
26.22%
Holding
155
New
7
Increased
94
Reduced
38
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globant
GLOB
|
+$31M |
| 2 |
Guidewire Software
GWRE
|
+$26.1M |
| 3 |
Phreesia
PHR
|
+$25.7M |
| 4 |
The Ensign Group
ENSG
|
+$21.5M |
| 5 |
GoDaddy
GDDY
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Protolabs
PRLB
|
+$27.5M |
| 2 |
Align Technology
ALGN
|
+$23.9M |
| 3 |
Five Below
FIVE
|
+$16.3M |
| 4 |
Verisk Analytics
VRSK
|
+$6.83M |
| 5 |
West Pharmaceutical
WST
|
+$6.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.23% |
| 2 | Healthcare | 21.28% |
| 3 | Industrials | 17.25% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Communication Services | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Target
TGT
$66.7B
| $411K | ﹤0.01% |
2,327
| – | – |
|
127
US Bancorp
USB
$98.9B
| $402K | ﹤0.01% |
8,637
| – | – |
|
128
Coca-Cola
KO
$387B
| $401K | ﹤0.01% |
7,304
-44
| -0.6% | -$2.27K |
|
129
Illumina
ILMN
$29B
| $372K | ﹤0.01% |
1,033
-45
| -4% | -$14.3K |
|
130
Bristol-Myers Squibb
BMY
$130B
| $337K | ﹤0.01% |
5,425
-400
| -7% | -$24.6K |
|
131
Costco
COST
$433B
| $323K | ﹤0.01% |
857
| – | – |
|
132
Vanguard Total Stock Market ETF
VTI
$650B
| $316K | ﹤0.01% |
1,624
| – | – |
|
133
Oracle
ORCL
$338B
| $311K | ﹤0.01% |
4,800
-220
| -4% | -$13.1K |
|
134
Waste Management
WM
$96B
| $295K | ﹤0.01% |
2,500
| – | – |
|
135
Colgate-Palmolive
CL
$74.3B
| $255K | ﹤0.01% |
2,984
-1,746
| -37% | -$144K |
|
136
Xcel Energy
XEL
$49.6B
| $254K | ﹤0.01% |
3,810
| – | – |
|
137
Hormel Foods
HRL
$14.3B
| $232K | ﹤0.01% |
+4,980
| New | +$243K |
|
138
Meta Platforms (Facebook)
META
$1.5T
| $222K | ﹤0.01% |
814
-10
| -1% | -$2.74K |
|
139
AbbVie
ABBV
$470B
| $219K | ﹤0.01% |
+2,040
| New | +$196K |
|
140
Nuveen ESG Mid-Cap Growth ETF
NUMG
$348M
| $210K | ﹤0.01% |
+4,247
| New | +$199K |
|
141
Union Pacific
UNP
$173B
| $208K | ﹤0.01% |
+1,000
| New | +$200K |
|
142
Amcor
AMCR
$20.9B
| $180K | ﹤0.01% |
3,060
| – | – |
|
143
Cabot Corp
CBT
$4.68B
| – | – |
-11,188
| Closed | -$403K |
|
144
Evolent Health
EVH
$385M
| – | – |
-21,609
| Closed | -$268K |
|
145
Trupanion
TRUP
$1.13B
| – | – |
-5,053
| Closed | -$399K |
|
Similar funds
BPS
VPC
WWA
SPC
U
SL
SCM
AAP
Riverbridge Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Riverbridge Partners held 155 positions worth $9.05B, up 26% from $7.17B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Riverbridge Partners deployed $444M of net new capital in Q4 2020, opening 7 new positions and adding to 94 existing holdings. Its largest new stake was Phreesia: 597,961 shares worth $32.4M.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Protolabs, an estimated $27.5M trimmed.
- Riverbridge Partners's largest Q4 2020 buy was Phreesia: 597,961 shares worth $32.4M.
- Riverbridge Partners added most to Globant in Q4 2020, an estimated $31M increase.
- Riverbridge Partners's biggest Q4 2020 reduction was Protolabs, cutting an estimated $27.5M.
- Riverbridge Partners fully exited Cabot Corp in Q4 2020, selling an estimated $403K.
- Riverbridge Partners's ten largest holdings make up 26% of its $9.05B portfolio in Q4 2020.
- Riverbridge Partners opened 7 new positions and closed 3 in Q4 2020.
- Riverbridge Partners's portfolio value rose 26% quarter-over-quarter to $9.05B.
Based on Riverbridge Partners's 13F filing for Q4 2020, filed 22 Jan 2021.